Breckenridge Pharmaceutical recalls

Breckenridge Pharmaceutical has 35 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 17 Jun 2026. 21 are still ongoing. 6 were reported in the last 12 months. The most frequent reason is nitrosamine impurity.

Total recalls35since 2015
Last 12 months6reported
Class I00% of total
Ongoing21latest 17 Jun 2026

Recalls per month, last 24 months

click a bar for that month

Severity split

Class I 0 0%Class II 32 91%Class III 3 9%

Why breckenridge pharmaceutical is recalled

By year

Ongoing breckenridge pharmaceutical recalls

21 active

All breckenridge pharmaceutical recalls, newest first

35 total
ReportedClassRecallCompanyReasonWhere
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 30mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules USP, 60mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60 mg, a.) bottle recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 30 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityAZ, IN, NJ
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityAZ, IN, NJ
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 40mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules USP, 30 mg, a.) bottles recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules USP, 60 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 30 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 30mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 20mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 30mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 20mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 20 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 30mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIDuloxetine Delayed-Release Capsules, USP, 60 mg recalledDuloxetineBreckenridge PharmaceuticalNitrosamine ImpurityNationwide
DrugCLASS IIClobazam Tablets, 20 mg, CIV recalled by Breckenridge PharmaceuticalBreckenridge PharmaceuticalManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIClobazam Tablets, 10 mg, CIV recalled by Breckenridge PharmaceuticalBreckenridge PharmaceuticalManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAlprazolam Tablets, USP, 2 mg, CIV recalledBreckenridge PharmaceuticalManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAlprazolam Tablets, USP, 0.5mg, CIV recalledBreckenridge PharmaceuticalManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAlprazolam Tablets, USP, 0.25mg, CIV recalledBreckenridge PharmaceuticalManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIAlprazolam Tablets, USP, 1 mg, CIV recalledBreckenridge PharmaceuticalManufacturing (CGMP) DeviationsNationwide
DrugCLASS IIOmeprazole Delayed-Release Capsules, USP, 20 mg recalledBreckenridge PharmaceuticalPotency & AssayNationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.